If we’re smart, positioning ourselves to benefit from the climate and clean energy transition does not require us to pick a ...

By holding rates steady at 4.25% to 4.5%, the Fed may be setting the stage for a prolonged wait-and-see approach—monitoring ...

We are pleased to share the January 2025 issue of Wilson Sonsini's Sustainability and ESG Advisory Practice Update. Each issue combines news, ...

Before Donald Trump took office, solar advocates were optimistic the feds would keep their funding commitments. Now, they’re not so sure.

IRA has unintended consequences on investment landscape for small- and large-molecule drugs stifling the development of new ...

To save taxpayer money and rebuild the economy, Congress should repeal Biden's poorly named Inflation Reduction Act ...

The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...

We have received text from H.R. 191: Inflation Reduction Act of 2025. This bill was received on 2025-01-03, and currently has 15 cosponsors. Here is a short summary of the bill: This bill ...

Panelists discuss how the inclusion of ibrutinib on the Inflation Reduction Act (IRA) negotiated drug price list could make it a more economically attractive first-line option, potentially influencing ...

On January 20, 2025, the White House issued an Executive Order titled Unleashing American Energy. Citing the detrimental effect of ...

Democrats sought answers from RFK Jr. on how the Trump administration would handle Medicare price negotiations after a short ...

An inflation gauge closely watched by the Federal Reserve rose slightly last month, the latest sign that some consumer prices remain stubbornly elevated, even as inflation is cooling in fits and start ...